Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success
RSS SUMMARY · AGGREGATED FROM TWSJ
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
Business
Auto & Transport Roundup: Market Talk
TWSJ·1h ago·3 min read
Business
The Revenge of the Publicists: How Comms Execs Stormed the C-Suite
TWSJ·1h ago·3 min read
Business
Not Your Father’s Country Club: Here Come the Private Racetracks
TWSJ·1h ago·3 min read
Sports
Trump, Timothée and $10,000 Nosebleeds: Loveable Knicks Brace for Game of Century
TWSJ·1h ago·3 min read
Related
On this beat
Health
Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot’s Side Effects
TWSJ·1h ago·3 min read
Health
Weight loss drug maker sinks 25% after new safety data spooks investors
CNBC·3h ago·3 min read
Health
Life After A Spinal Injury: A Guide to Physical And Mental Recovery
AOHL·4h ago·3 min read
Health
Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch
TWSJ·6h ago·3 min read